Eversept Partners, Eversept 1 LLC and Kamran Moghtaderi jointly report beneficial ownership of 6,144,384 shares of Community Health Systems, Inc. common stock, representing approximately 4.4% of the outstanding shares based on a 140,306,440-share base. The reporting persons state they have sole voting and dispositive power over 5,463,507 shares and shared voting and dispositive power over 680,877 shares (the latter held in managed accounts). The filing clarifies the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer.
Positive
None.
Negative
None.
Insights
TL;DR: A disclosed 4.4% position in CYH shows notable institutional interest but falls below a controlling stake.
The filing documents a meaningful minority holding of 6.14 million shares with predominant sole voting and dispositive authority over those shares. For investors, this signals active ownership and monitoring by a specialized investment manager while remaining non-controlling. The declaration that the shares are held in the ordinary course of business reduces immediate governance-change implications.
TL;DR: Disclosure shows concentrated influence over held shares but no asserted intent to seek control.
The reporting group holds a concentrated economic and voting position within its overall stake: 5,463,507 shares under sole control versus 680,877 shared. The Schedule 13G/A format and certification that holdings are not for the purpose of changing control are consistent with passive or monitoring investor behavior rather than an activist campaign, limiting immediate governance risk.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 6)
Community Health Systems, Inc.
(Name of Issuer)
Common Stock, par value $0.01 per share
(Title of Class of Securities)
203668108
(CUSIP Number)
06/30/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
203668108
1
Names of Reporting Persons
Eversept Partners, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
5,463,507.00
6
Shared Voting Power
680,877.00
7
Sole Dispositive Power
5,463,507.00
8
Shared Dispositive Power
680,877.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,144,384.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.4 %
12
Type of Reporting Person (See Instructions)
IA
Comment for Type of Reporting Person: *See Item 4 of the Schedule 13G
SCHEDULE 13G
CUSIP No.
203668108
1
Names of Reporting Persons
Eversept 1 LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
5,463,507.00
6
Shared Voting Power
680,877.00
7
Sole Dispositive Power
5,463,507.00
8
Shared Dispositive Power
680,877.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,144,384.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.4 %
12
Type of Reporting Person (See Instructions)
HC
Comment for Type of Reporting Person: *See Item 4 of the Schedule 13G
SCHEDULE 13G
CUSIP No.
203668108
1
Names of Reporting Persons
Kamran Moghtaderi
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
5,463,507.00
6
Shared Voting Power
680,877.00
7
Sole Dispositive Power
5,463,507.00
8
Shared Dispositive Power
680,877.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,144,384.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.4 %
12
Type of Reporting Person (See Instructions)
HC, IN
Comment for Type of Reporting Person: *See Item 4 of the Schedule 13G
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Community Health Systems, Inc.
(b)
Address of issuer's principal executive offices:
4000 Meridian Boulevard, Franklin, TN, 37067
Item 2.
(a)
Name of person filing:
This statement is jointly filed by and on behalf of Eversept Partners, L.P., a Delaware limited partnership (the "Investment Manager"), Eversept 1 LLC, a Delaware limited liability company (the "IM GP") and Kamran Moghtaderi (collectively referred herein as "Reporting Persons"). The Investment Manager is the investment manager of advisory clients and may be deemed to indirectly beneficially own securities owned by its advisory clients. The IM GP is the general partner of the Investment Manager and may be deemed to indirectly beneficially own securities owned by the Investment Manager. Mr. Moghtaderi is the sole manager of and may be deemed to beneficially own securities beneficially owned by the IM GP. Eversept's advisory clients are the record and direct beneficial owners of the securities covered by this statement.
Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial owner of any securities covered by this statement.
Each Reporting Person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for the purpose of Section 13(d) or 13(g) of the Act. Each of the Reporting Persons declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purpose of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities of the issuer or otherwise with respect to the issuer or any securities of the issuer or (ii) a member of any group with respect to the issuer or any securities of the issuer.
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of each of the Reporting Persons is c/o Eversept Partners, L.P., 444 Madison Avenue, 22nd Floor, New York, NY 10022.
(c)
Citizenship:
See Item 4 on the cover page hereto.
(d)
Title of class of securities:
Common Stock, par value $0.01 per share
(e)
CUSIP No.:
203668108
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
6,144,384
(b)
Percent of class:
4.4%**
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
5,463,507
(ii) Shared power to vote or to direct the vote:
680,877*
(iii) Sole power to dispose or to direct the disposition of:
5,463,507
(iv) Shared power to dispose or to direct the disposition of:
680,877*
* Note: As of the close of business on June 30, 2025, Eversept and its controlling persons beneficially owned 6,144,384 Shares, including 680,877 Shares held in Eversept's Managed Accounts.
** Note: As of June 30, 2025, Eversept and its controlling persons were the beneficial owners of approximately 4.4% of the outstanding Shares, based on 140,306,440 shares of Common Stock of the Issuer outstanding as of April 17, 2025, as reported in the Issuer's Form 10-Q filed on April 24, 2025, including 0.5% of the outstanding Shares held in Eversept's Managed Accounts.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
The filing reports beneficial ownership of 6,144,384 shares of CYH common stock.
What percentage of CYH does Eversept own?
Eversept and related reporting persons own approximately 4.4% of the outstanding common stock, based on a 140,306,440-share base.
How much voting control does Eversept have over its CYH shares?
They report sole voting power over 5,463,507 shares and shared voting power over 680,877 shares.
Is Eversept claiming the stake is intended to change control of CYH?
No. The filing certifies the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer.
Who are the reporting persons on the Schedule 13G/A for CYH?
The statement is jointly filed by Eversept Partners, L.P., Eversept 1 LLC, and Kamran Moghtaderi.
